Kasirer-Friede Ana, Kahn Mark L, Shattil Sanford J
Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0726, USA.
Immunol Rev. 2007 Aug;218:247-64. doi: 10.1111/j.1600-065X.2007.00532.x.
Stable platelet adhesion to extracellular matrices and the formation of a hemostatic or pathological thrombus are dependent on integrin alphaIIbbeta3, also known as GPIIb-IIIa. However, maximal platelet responses to vascular injury may involve the participation of other integrins expressed in platelets (alphaVbeta3, alpha2beta1, alpha5beta1, and alpha6beta1). Platelet membrane 'immunoreceptors' contain at least one subunit with an extracellular immunoglobulin superfamily domain and/or an intracellular stimulatory immunoreceptor tyrosine-based activation motif (ITAM) or immunoreceptor tyrosine-based inhibitory motif (ITIM). Platelet ITAM receptors, such as FcgammaRIIA and the GPVI-FcRgamma complex, promote activation of integrins, while ITIM receptors, such as platelet-endothelial cell adhesion molecule-1, may promote their inhibition. This review summarizes the structure and function of platelet integrins and immunoreceptors, the emerging functional relationships between these receptor classes, and the consequences of their interaction for platelet function in hemostasis and thrombosis.
Immunol Rev. 2007-8
Immunol Rev. 2007-8
Semin Thromb Hemost. 1995
Thromb Res. 2019-2-10
Sci STKE. 2007-3-13
Transfus Apher Sci. 2003-6
Thromb Haemost. 2001-7
Haematologica. 2023-7-1
Thromb Haemost. 1995-7
Front Immunol. 2025-7-7
Front Pharmacol. 2025-1-20
Int J Nanomedicine. 2023
Pharmacol Rep. 2022-12
J Nanobiotechnology. 2022-5-31
Front Immunol. 2022
Cardiol Res Pract. 2021-2-23